Long-term Survival With Afatinib in a Patient With Lung Adenocarcinoma Harboring Double Uncommon EGFR L861Q and G719X Mutations
Keyword(s):
Keyword(s):
2018 ◽
Vol 10
(4)
◽
pp. 2070-2078
◽
Keyword(s):